KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries
2024年7月5日 - 1:01AM
KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic
Cardiac Surgeries
King Faisal Specialist Hospital & Research Centre (KFSH&RC)
has achieved a significant milestone in its Robotic Cardiac Surgery
Program, which was initiated in February 2019. Within its first
year, the program performed 105 cardiac procedures. As of today,
400 robotic cardiac surgeries have been performed with a remarkable
98% survival rate.
KFSH&RC is leading a healthcare revolution
by harnessing robotics to transform patient care and elevate
surgical precision. Recognized as one of the top hospitals in
robotic surgeries, it has cultivated a robust portfolio of
expertise and ground-breaking achievements, solidifying its
position on the global stage.
KFSH&RC’s journey in robotic surgery began
in 2003. Over the years, with the development of the machine to the
fourth generation, the volume has grown significantly in performing
robotic surgeries across various specialties, including urology,
cardiology, transplant, and general surgeries.
Recognized globally, the program boasts the
highest volume of robotic cardiac surgeries outside the USA and
ranks in the top five worldwide according to American Global
Medical Surgical Robotics (GMSR), a training subsidiary for Da
Vinci Robotics. KFSH&RC Robotics Cardiac Program is also
acknowledged as the second start-up and leading program for robotic
aortic valve replacement (AVR) globally.
Renowned for addressing some of the most complex
cases in cardiac surgery, the program includes operations on
children under 18, a feat no other hospital in the world performs
using robotics. The complexity and excellence of the program are
further demonstrated by its handling of high-risk patients,
including those with morbid obesity and those requiring redo
surgeries. Notably, KFSH&RC performs robotic surgeries on
3-time redo cardiac patients, an accomplishment unmatched by any
hospital in the USA.
KFSH&RC has introduced innovative cardiac
procedures, such as robotic multi-valve operations and robotic
aortic valve replacements, achieving new heights in the field.
These advancements in robotic cardiac surgery have significantly
improved patient outcomes, reducing blood transfusions, mechanical
ventilation time, and length of stay by over 50%, and lowering
costs by 40% compared to conventional methods. The program's
proctoring and training initiatives in Germany, the USA, and other
countries have further enhanced KFSH&RC’s international
influence and expertise in robotic cardiac surgery.
It is noteworthy that King Faisal Specialist
Hospital & Research Centre has been ranked first in the Middle
East and Africa and 20th globally, in the list of the world’s top
250 Academic Medical Centres for the second consecutive year and
recognized as the most valuable healthcare brand in the Kingdom and
the Middle East, according to the 2024 Brand Finance rankings.
Additionally, in the same year, it was ranked among the world's
best 250 hospitals by Newsweek magazine.
For more information, please
contact:Mr. Essam AlZahrani, Acting Director of Media
Affairs, 0555254429Mr. Abdullah Alown, Director of Media
Coordination, 0556294232
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ef261fba-c64b-4bad-8160-ac586e235a0f